SynthesisMovement disorders clinical practice2026
Enteral Nutrition in Idiopathic Parkinson's Disease and Atypical Parkinsonism: A Systematic Review.
Synthesis in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDysphagia and malnutrition are common in advanced Parkinson's disease and atypical parkinsonism. There is a lack of evidence to guide the use of enteral nutrition in these situations, including whether it improves survival or reduces aspiration pneumonia.
objectivesTo systematically review the impact of enteral nutrition in Parkinson's disease and atypical parkinsonism on survival and morbidity (including aspiration pneumonia).
methodsWe followed PRISMA guidelines and conducted searches using PubMed and Scopus databases. ROBINS-I V2 (n = 2) and JBI Cohort Study (n = 14) checklists were used to assess risk of bias.
resultsWe identified 16 eligible studies. Risk of bias was moderate or high in all studies. Reported enteral feeding rates in parkinsonian disorders varied widely. The rate of aspiration pneumonia following enteral feeding was around 40% in those with parkinsonism. The weighted median survival following gastrostomy insertion in Parkinson's disease was 1.35 years (n = 83; 3 studies) and in atypical parkinsonism 1.49 years (n = 46; 2 studies). One study in atypical parkinsonism found improved survival with enteral feeding compared to at-risk feeding (24 vs. 12 months), whilst another in Parkinson's disease found no difference in mortality rates.
conclusionsThere is a lack of high-quality evidence on the impact of enteral feeding on prognosis and morbidity. It is unclear whether enteral feeding improves survival compared to at-risk feeding. There is a need for more robust evidence such as through enteral feeding registries with standardized data collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.